Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
H.P. Acthar Gel (repository corticotropin injection) treatment of patients with multiple sclerosis and diabetes.
Inflammaging and Frailty Status Do Not Result in an Increased Extracellular Vesicle Concentration in Circulation.
Response to letter regarding article 'Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder'.
The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis.
Hereditary and metabolic myelopathies.
Effectiveness and safety of natalizumab in real-world clinical practice: Review of observational studies.
Myelin-targeted, texaphyrin-based multimodal imaging agent for magnetic resonance and optical imaging.
Aldynoglia cells and modulation of RhoGTPase activity as useful tools for spinal cord injury repair.
Therapeutic antibodies for spinal cord injury.
A nerve conduit containing a vascular bundle and implanted with bone marrow stromal cells and decellularized allogenic nerve matrix.
Activation of peroxisome proliferator-activated receptor-γ by a 12/15-lipoxygenase product of arachidonic acid: a possible neuroprotective effect in the brain after experimental intracerebral hemorrhage.
Genetic Variants and Multiple Sclerosis Risk Gene SLC9A9 Expression in Distinct Human Brain Regions.
Enhancing Approaches to the Identification and Management of Pseudobulbar Affect.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Compromised blood-brain barrier permeability: Novel mechanism by which circulating angiotensin II signals sympathoexcitatory centers during hypertension.
Administrative databases for observational studies in multiple sclerosis: power or peril?
Anthraquinones As Pharmacological Tools and Drugs.
Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients.
miRNAs As Emerging Regulators of Oligodendrocyte Development and Differentiation.
Ciliary neurotrophic factor protects retinal ganglion cells from secondary cell death during acute autoimmune optic neuritis in rats.
Vitamin D status in patients with MS is negatively correlated with depression, but not with fatigue.
Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.
Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Novel fMRI working memory paradigm accurately detects cognitive impairment in multiple sclerosis.
Sensory information treatment during disturbed standing posture in chronic acquired demyelinating polyneuropathies (CADP).
Pages
« first
‹ previous
…
780
781
782
783
784
785
786
787
788
…
next ›
last »